Associated with biallelic mutations in ADA2 (previously CECR1, cat eye syndrome chromosome region, candidate 1), it was first described in 2014, as a disease similar to polyarteritis nodosa with early‐onset stroke, systemic inflammation, vasculopathy, and mild immunodeficiency.2, 3. This evidence concerns the gene ADA2 and Immunodeficiency.